35 results
8-K
EX-99.1
INBX
Inhibrx Biosciences, Inc.
24 May 24
Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
4:08pm
. For more information, please visit www.inhibrx.com.
About Sanofi
Sanofi is an innovative global healthcare company, driven by one purpose: chase
8-K
EX-99.1
INBX
Inhibrx Biosciences, Inc.
8 May 24
Other Events
4:42pm
information, please visit www.inhibrx.com.
About Sanofi
Sanofi is an innovative global healthcare company, driven by one purpose: chase the miracles
DEFM14A
INBX
Inhibrx Biosciences, Inc.
26 Apr 24
Proxy related to merger
4:06pm
, a leading global healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic … .
Parent is a Pennsylvania corporation and is a wholly owned indirect subsidiary of Sanofi, a leading global healthcare company, focused on patient needs
DEFA14A
INBX
Inhibrx Biosciences, Inc.
23 Jan 24
Additional proxy soliciting materials
6:38am
Section 3.22
Healthcare Regulatory Compliance
Section 3.23
Data Privacy and Information Security
Section 3.24
Insurance
Section 3.25
Takeover Statutes … Healthcare Laws or with respect to any Company Product, and, to the Knowledge of the Company, neither the FDA nor any comparable Governmental Authority
8-K
EX-99.1
y7vm8c8qapzq bgaduv
23 Jan 24
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
6:35am
8-K
EX-2.1
nfddsgt1a5r8bfz
23 Jan 24
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
6:35am
8-K
EX-10.1
glbjq ly8e4
29 Aug 23
Inhibrx Announces $200 Million Private Placement Financing
9:03am
DEF 14A
mypb3 5ie4zbkw
28 Apr 21
Definitive proxy
7:51am
10-K
l9kipb302a8njbz qlv
12 Mar 21
Annual report
8:46am
10-Q
0uodslrnlg191dj6ay
13 Nov 20
Quarterly report
4:09pm
424B4
7rvkr0firjx6n10g6si2
19 Aug 20
Prospectus supplement with pricing info
5:21pm
CORRESP
ov4m3t2n
5 Aug 20
Correspondence with SEC
12:00am
CORRESP
dc0v5wt1
3 Aug 20
Correspondence with SEC
12:00am